XML 45 R31.htm IDEA: XBRL DOCUMENT v3.25.2
Segment Reporting (Tables)
 6 Months Ended
Jun. 30, 2025
Segment Reporting [Abstract]  
Summary of Reportable Revenues by Geographic Regions The following table summarizes reportable revenue by geographic regions (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2025202420252024
Testing services revenue
United States$61,670 $70,699 $123,108 $124,349 
Rest of World363 219 846 406 
$62,033 $70,918 $123,954 $124,755 
Product revenue
United States$7,193 $6,575 $13,700 $11,851 
Rest of World4,640 4,035 8,943 7,353 
$11,833 $10,610 $22,643 $19,204 
Patient and digital solutions revenue
United States$12,778 $10,694 $24,698 $20,278 
Rest of World35 52 69 86 
$12,813 $10,746 $24,767 $20,364 
Total revenue
Total United States$81,641 $87,968 $161,506 $156,478 
Total Rest of World5,038 4,306 9,858 7,845 

$86,679 $92,274 $171,364 $164,323 
Summary of Long-Lived Assets Consisting of Property and Equipment, Net by Geographic Regions
The following table summarizes long-lived assets, consisting of property and equipment, net, by geographic regions (in thousands):
June 30, 2025December 31, 2024
Long-lived assets:
United States$31,677 $33,286 
Rest of World257 266 
Total$31,934 $33,552 
Schedule of Reconciliation of Revenue to Net Loss
The following table summarizes the reconciliation to net loss (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2025202420252024
Revenue:
Testing services revenue
$62,033 $70,918 $123,954 $124,755 
Product revenue
11,833 10,610 22,643 19,204 
Patient and digital solutions revenue
12,813 10,746 24,767 20,364 
Total revenue
86,679 92,274 171,364 164,323 
Less:
Cost of testing services1
14,731 13,622 29,134 26,468 
Cost of product1
4,431 5,662 9,374 10,269 
Cost of patient and digital solutions1
7,929 6,805 15,273 13,120 
Personnel cost
29,330 30,843 60,073 57,371 
Professional and legal fees
12,348 10,033 22,540 22,206 
Research materials and clinical trials expense
4,057 4,724 7,231 8,204 
Depreciation and amortization expense
2,951 3,108 5,901 6,486 
Stock-based compensation expense
9,424 16,399 18,355 32,972 
Litigation settlement expense
350 — 5,710 — 
Transformational initiative costs2
1,871 — 1,871 — 
Other segment items3
10,189 8,527 19,970 17,450 
Interest income, net
(2,364)(2,826)(5,147)(5,712)
Segment and condensed consolidated net loss
$(8,568)$(4,623)$(18,921)$(24,511)
1 Cost of testing services, cost of product and cost of patient and digital solutions include depreciation expense
2 Transformational initiative costs consist of consulting expenses which relate to the Company's ongoing transformation strategy that we have undertaken as a series of initiatives focused on operational excellence, enterprise-wide efficiency, and long-term strategic growth.
3 Other segment items include the following: acquisition costs, software expenses, corporate expenses, rent and maintenance expense, travel and event related expense, and other expenses (income)